Paper Details
- Home
- Paper Details
Effects of valproic acid and magnesium sulphate on rocuronium requirement in patients undergoing craniotomy for cerebrovascular surgery.
Author: DoS-H, HwangJ-W, JeonY-T, KimM-H
Original Abstract of the Article :
BACKGROUND: Many anti-epileptics cause resistance to non-depolarizing neuromuscular blocking agents, but this has not been reported for valproic acid (VPA). We hypothesized that VPA would increase the rocuronium requirement and that magnesium sulphate (MgSO(4)) may reduce this increase. METHODS: Fi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/bja/aes218
データ提供:米国国立医学図書館(NLM)
Valproic Acid Can Increase Rocuronium Requirement in Patients Undergoing Craniotomy
Navigating the complex world of medications and their interactions is like navigating a vast desert – you need a compass and a keen eye for detail. This study investigated the effect of valproic acid (VPA), a common anti-epileptic drug, on the effectiveness of the muscle relaxant rocuronium. The study found that VPA actually increased the amount of rocuronium needed to achieve the desired muscle relaxation effect in patients undergoing craniotomy, a surgery on the skull.
Magnesium Sulfate Can Attenuate the Effect of Valproic Acid
The researchers then explored whether magnesium sulfate (MgSO4) could offset the increased rocuronium requirement caused by VPA. Their findings were promising: MgSO4 infusion significantly attenuated the increase in rocuronium requirement, suggesting a potential strategy for managing this drug interaction.
Implications for Patients and Physicians
This study highlights the importance of understanding drug interactions, especially in patients receiving multiple medications. It also suggests that careful monitoring and adjustments to medication dosages may be necessary when VPA is used in conjunction with rocuronium. This information is crucial for both patients and physicians, ensuring safe and effective treatment outcomes.
Dr. Camel's Conclusion
This research provides valuable insights into the interaction between valproic acid and rocuronium. Just as a skilled camel handler understands the nuances of their animal's behavior, physicians need to be aware of potential drug interactions to provide optimal patient care. This study emphasizes the importance of careful consideration of drug combinations and the potential need for dose adjustments.
Date :
- Date Completed 2012-10-23
- Date Revised 2018-12-01
Further Info :
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.